JLABS | Science 1st – Oncology: Harnessing Immunotherapies of the Future

September 30, 2015

Share :

Presented by Johnson & Johnson Innovation, JLABS

Time:  2:00PM - 4:30PM
Location:  Lobby

RSVP LabCentral residents and alumni please request free sign up code from Clancy prior to registering

Program Overview:
Immunotherapy harnesses the body's own immune system to fight cancer and it is revolutionizing cancer treatment. Unprecedented outcomes have been observed in cancers that were once perceived as hopeless such as melanoma and lung cancer. Nonetheless, not all patients respond to treatment, and an understanding of efficacy drivers is lacking. Can co-clinical trials provide the necessary mechanistic insight to identify the right immunotherapies and combinations to improve patient outcomes and speed up drug approvals?

Johnson & Johnson Innovation, JLABS (JLABS) is bringing together top experts to discuss the latest developments, challenges, and opportunities with the co-clinical approach to immunotherapy development. Join our speakers as they present the latest research in this area and engage in a panel discussion to obtain insights into novel immunotherapies of the future.

2:00pm | Registration Opens
2:30pm | Presentations
3:15pm | Panel discussion
4:00pm | Reception
4:30pm | Close 

Wendy Garrett | Associate Professor, Immunology & Infectious Diseases, Harvard T. H. Chan School of Public Health
Kwok-Kin Wong | Professor of Medicine, Dana-Farber Cancer Institute/Harvard Medical School 
[moderator] Kathryn Packman | Scientific Director Oncology Collaborations, Janssen Research & Development, LLC

About the Science First series:
The purpose of the Science First series, sponsored by Johnson & Johnson Innovation, JLABS, is to bring together top experts to explore a pressing topic in their scientific field. It is a chance for local scientists, researchers, and entrepreneurs to present and dialogue on new discoveries, advancing techniques, and other cutting-edge science themes.